Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (181-190 of 266) with videos related to

Pageof 27
Sort By:
The Prostate|May 28, 2015
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determinationChanning J Paller, Michelle A Rudek, Xian C Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2017
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT CohortsElizabeth A Platz, Ibrahim Kulac, John R Barber, et al.
Cancer Cell|March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigenCharles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.
Cell|May 21, 2021
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophagesAleksandar Obradovic, Nivedita Chowdhury, Scott M Haake, et al.
Prostate Cancer and Prostatic Diseases|March 21, 2018
Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerBenjamin Benzon, Stephanie A Glavaris, Brian W Simons, et al.
The Lancet. Oncology|October 13, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage studyDavid Olmos, Daniel Brewer, Jeremy Clark, et al.
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.
NPJ Genomic Medicine|January 22, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancerHannah E Bergom, Laura A Sena, Abderrahman Day, et al.
The American Journal of Surgical Pathology|August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic PatternGenevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Pageof 27

Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
The Prostate|May 28, 2015
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determinationChanning J Paller, Michelle A Rudek, Xian C Zhou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2017
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT CohortsElizabeth A Platz, Ibrahim Kulac, John R Barber, et al.
Cancer Cell|March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigenCharles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.
Cell|May 21, 2021
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophagesAleksandar Obradovic, Nivedita Chowdhury, Scott M Haake, et al.
Prostate Cancer and Prostatic Diseases|March 21, 2018
Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerBenjamin Benzon, Stephanie A Glavaris, Brian W Simons, et al.
The Lancet. Oncology|October 13, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage studyDavid Olmos, Daniel Brewer, Jeremy Clark, et al.
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.
NPJ Genomic Medicine|January 22, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancerHannah E Bergom, Laura A Sena, Abderrahman Day, et al.
The American Journal of Surgical Pathology|August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic PatternGenevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Pageof 27